GSK3B and Parkinson disease: Another possible mechanism by which 18 can decrease α-synuclein protein expression in cellular model of PD is through the downregulation and partial inhibition of GSK-3β (glycogen synthase kinase 3 beta) which has been shown to protect the dopaminergic neurons from various stress-induced injuries.